Carotid artery disease and stroke in patients with peripheral arterial disease. The role of inflammation

Monaldi Archives for Chest Disease - Cardiac Series

Volumn 72, Issue 1, 2009, Pages 10-17

  Sirico, Giusy ^a   Spadera, Lucrezia ^a   De Laurentis, Mario ^a   Brevetti, Gregorio ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Carotid artery disease; Inflammation; Peripheral arterial disease; Polyvascular disease; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ARTERY DISEASE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; ATTENTION; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CELL COUNT; CELL INFILTRATION; CHRONIC INFLAMMATION; COMPARATIVE STUDY; HEART MUSCLE ISCHEMIA; HUMAN; LEUKOCYTE; MACROPHAGE; NEUTROPHIL; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; STROKE; ECHOGRAPHY; INFLAMMATION; PERIPHERAL VASCULAR DISEASE;

ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; HUMANS; INFLAMMATION; PERIPHERAL VASCULAR DISEASES; STROKE;

EID: 69849092917     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: 10.4081/monaldi.2009.337     Document Type: Review

References (85)

1. Solberg LA, Strong JP. Risk factors for atherosclerotic lesions: a review of autopsy studies. Atherosclerosis 1983; 3: 187-187
2. Goldstein JA. Angiographic plaque complexity: the tip of the unstable plaque iceberg. J Am Coll Cardiol 2002; 39: 1464-1467
3. Brevetti G, Oliva G, Silvestro A, Scopacasa F, Chiariello M; Peripheral Arteriopathy and Cardiovascular Events (PACE) Study Group. Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 2004; 175(1): 131-138 (Pubitemid 38746919)
4. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edimburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-392
5. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996; 25(2): 282-290 (Pubitemid 26137108)
6. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18(2): 185-192 (Pubitemid 28277594)
7. Steg PG, Bhatt DL, Wilson PW, et al; REACH Registry Investigators. One-year cardiovascular event rates in out-patients with atherothrombosis. JAMA 2007; 297(11): 1197-1206
8. Dormandy J, Mahir M, Ascady G, et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg 1989; 30(1): 50-57 Review. (Pubitemid 19080681)
9. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. Am J Cardiol 1994; 74(1): 64-65 (Pubitemid 24196317)
10. Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984; 199(2): 223-233
11. Hirsch AT, Halverson SL, Treat-Jacobson D, et al. The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. Vasc Med 2001; 6(2): 87-96. (Pubitemid 32791509)
12. Darbar D, Gillespie N, Main G, et al. Prediction of late cardiac events by dipyridamole thallium scintigraphy in patients with intermittent claudication and occult coronary artery disease. Am J Cardiol 1996; 78(7): 736-740 (Pubitemid 126657140)
13. Perrone-Filardi P, Cuocolo A, Brevetti G, et al. Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol 2005; 96(9): 1337-1341 (Pubitemid 41505421)
14. Papamichael CM, Lekakis JP, Stamatelopoulos KS, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 2000; 86(6): 615-618
15. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25(6): 1172-1181 (Pubitemid 27013522)
16. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326(6): 381-386
17. Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke 1997; 28(2): 348-353
18. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88(3): 837-845
19. Mostaza JM, González-Juanatey JR, Castillo J, Lahoz C, Fernández-Villaverde JM, Maestro-Saavedra FJ. Prevalence of carotid stenosis and silent myocardial ischemia in asymptomatic subjects with a low ankle-brachial index. J Vasc Surg 2008. [Epub ahead of print].
20. Gregorio Brevetti, MD, Giusy Sirico, MD, Simona Lanero, MD, Julieta Isabel De Maio, MD, Eugenio Laurenzano, MD, Giuseppe Giugliano, MD. The prevalence of hypoechoic carotid plaques is greater in peripheral than in coronary artery disease and is related to the neutrophil count. J Vasc Surg 2008; 47: 523-529
21. Burek KA, Sutton-Tyrrell K, Brooks MM, et al. Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 1999; 34(3): 716-721 (Pubitemid 29436176)
22. Kurvers HA, van der Graaf Y, Blankensteijn JD, Visseren FL, Eikelboom BC; SMART Study Group. Screening for asymptomatic internal carotid artery stenosis and aneurysm of the abdominal aorta: comparing the yield between patients with manifest atherosclerosis and patients with risk factors for atherosclerosis only. J Vasc Surg 2003; 37: 1226-1233
23. Cheng SW, Wu LL, Lau H, Ting AC, Wong J. Prevalence of significant carotid stenosis in Chinese patients with peripheral and coronary artery disease. Aust N Z J Surg 1999; 69: 44-47. (Pubitemid 29051362)
24. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996; 348(9038): 1329-1339
25. Langsfield M, Gray-Weale AC, Lusby RJ. The role of plaque morphology and diameter reduction in the development of new symptoms in asymptomatic carotid arteries. J Vasc Surg 1989; 9: 548-557
26. Barnett HJ, Gunton RW, Eliasziw M, et al. Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA 2000; 283: 1429-1436 (Pubitemid 30151821)
27. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 2002; 15(6): 439-446 (Pubitemid 35387383)
28. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92(3): 657-671 Review
29. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993; 69(5): 377-381 (Pubitemid 23171108)
30. Fuster V, Lewis A. Connor memorial lecture: mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2126-2146. (Pubitemid 24979909)
31. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985; 53: 363-373.
32. Richardson PD, Davies MJ, Born GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989; 2: 941-994
33. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
34. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994; 90: 775-778. (Pubitemid 24242744)
35. Tauth J, Pinnow E, Sullebarger JT, et al. Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia. Am J Cardiol 1997; 80(10): 1352-1355 (Pubitemid 27513342)
36. Grønholdt MLM, Nordestgaard BG, Wiebe BM, Wilhjelm JE, Sillesen H. Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content. Circulation 1998; 97: 34-40.
37. Lal BK, Hobson RW 2nd, Pappas PJ, et al. Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaques. J Vasc Surg 2002; 35: 1210-1217
38. Geroulakos G, Ramaswami G, Nicolaides A, et al. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg 1993; 80(10): 1274-1277 (Pubitemid 23313157)
39. Brevetti G, Sirico G, Giugliano G, et al. Prevalence of hypoechoic carotid plaques in coronary artery disease: relationship with coexistent peripheral arterial disease and leukocyte number. Vascular Medicine 2008; 00: 1-7.
40. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
41. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126.
42. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
43. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001; 104: 503-516.
44. Jie J. Cao, Alice M. Arnold, Teri A. Manolio, et al. Association of Carotid Artery Intima-Media Thickness, Plaques, and C-Reactive Protein With Future Cardiovascular Disease and All-Cause Mortality: The Cardiovascular Health Study. Circulation 2007; 116: 32,38.
45. Philip S. Mullinex, MD; Scott R. Steele, MD; Matthew J. Martin, MD; Benjamin W. Starnes, MD; Charles A. Andersen, MD. C-reactive Protein Level and Traditional Vascular Risk Factors in the Prediction of Carotid Stenosis. Arch Surg 2007; 142(11): 1066-1071.
46. Martin Schillinger, MD; Markus Exner, MD; Wolfgang Mlekusch, MD, et al. Inflammation and Carotid Artery-Risk for Atherosclerosis Study (ICARAS). Circulation 2005; 111: 2203-2209.
47. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991; 325(7): 445-453
48. Yamagami H, Kitagawa K, Nagai Y, et al. Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques. Stroke 2004; 35: 677-681. (Pubitemid 38280840)
49. Alvarez Garcia B, Ruiz C, Chacon P, Sabin JA, Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 2003; 38(5): 1018-1024 (Pubitemid 37409637)
50. Lombardo A, Biasucci LM, Lanza GA, et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004; 109(25): 3158-3163
51. Jander S, Sitzer M, Schumann R, et al. Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 1998; 29(8): 1625-1630 (Pubitemid 28365585)
52. Grønholdt ML, Nordestgaard BG, Bentzon J, et al. Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels. J Vasc Surg 2002; 35(1): 137-145 (Pubitemid 44725782)
53. Handberg A, Skjelland M, Michelsen AE, et al. Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability. Stroke 2008; 39(11): 3092-3095
54. Kunte H, Amberger N, Busch MA, Rücken RI, Meiners S, Harms L. Markers of instability in high-risk carotid plaques are reduced by statins. J Vasc Surg 2008; 47(3): 513-522 (Pubitemid 351258283)
55. McDermott MM, Guralnik JM, Corsi A, et al. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J 2005; 150(2): 276-281 (Pubitemid 41116253)
56. Brevetti G, Martone VD, de Cristofaro T, et al. High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Thromb Haemost 2001; 85(1): 63-66 (Pubitemid 32050944)
57. Silvestro A, Scopacasa F, Ruocco A, et al. Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. Vasc Med 2003; 8(4): 225-232 (Pubitemid 38585135)
58. Brevetti G, Piscione F, Silvestro A, et al. Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis. Thromb Haemost 2003; 89(6): 1058-1063 (Pubitemid 36798158)
59. Erren M, Reinecke H, Junker R, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19(10): 2355-2363 (Pubitemid 29477836)
60. Rossi A, Franceschini L, Fusaro M, et al,. Carotid atherosclerotic plaque instability in patients with acute myocardial infarction. Int J Cardiol 2006; 111(2): 263-266 (Pubitemid 44107566)
61. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005; 112(7): 976-983 (Pubitemid 41170265)
62. Brevetti G, Schiano V, Laurenzano E, et al. Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. Eur Heart J 2008; 29(2): 150-152 (Pubitemid 351164877)
63. Pasterkamp G, Schoneveld AH, van der Wal AC, et al. Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. Arterioscler Thromb Vasc Biol 1999; 19(1): 54-58 (Pubitemid 29031912)
64. Vink A, Schoneveld AH, Richard W, et al. Plaque burden, arterial remodeling and plaque vulnerability: determined by systemic factors? J Am Coll Cardiol 2001; 38(3): 718-723 (Pubitemid 32835742)
65. Brevetti G, Piscione F, Cirillo P, et al. In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction. Atherosclerosis 2008; 201(2): 440-446
66. Sirico G, Brevetti G, Lanero S, Laurenzano E, Luciano R, Chiariello M. Echolucent femoral plaques entail higher risk of echolucent carotid plaques and a more severe inflammatory profile in peripheral arterial disease. J Vasc Surg 2008. [Epub ahead of print].
67. Rothwell PM, Villagra R, Gibson R, Donders RC, Warlow CP. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet 2000; 355(9197): 19-24. (Pubitemid 30072178)
68. Bekos C, Pieri L, Angelides N, Moros I. Prevalence of multifocal atherosclerosis and comorbidity on symptomatic Cypriot inpatients. Int Angiol 2008; 27(5): 419-425
69. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371(9624): 1612-1623.
70. Salameh MJ, Rundek T, Boden-Albala B, et al. Self-reported peripheral arterial disease predicts future vascular events in a community-based cohort. J Gen Intern Med 2008; 23(9): 1423-1428
71. Tsai AW, Folsom AR, Rosamond WD, Jones DW. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke 2001; 32(8): 1721-1724
72. Ovbiagele B. Association of ankle-brachial index level with stroke. J Neurol Sci 2008. [Epub ahead of print].
73. Abbott RD, Rodriguez BL, Petrovitch H, et al. Ankle-brachial blood pressure in elderly men and the risk of stroke: the Honolulu Heart Program. J Clin Epidemiol 2001; 54(10): 973-978 (Pubitemid 32893964)
74. Chamorro A. Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis 2004; 17 (Suppl 3): 1-5.
75. Musicant SE, Taylor LM Jr, Peters D, et al. J Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease. Vasc Surg 2006; 43(4): 772-780
76. Hogh AL, Joensen J, Lindholt JS, Jacobsen MR, Ostergaard L. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease. Vasc Endovascular Surg 2008; 42(4): 341-347
77. Ridker PM, Hennekens CH, Stampfer MJ & Wang F. (1998) Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation; 98: 2796-2799.
78. Rost NS, Wolf PA, Kase CS, et al. (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32: 2575-2579.
79. Gussekloo J, Schaap MCL, Frölich M, Blauw GJ & Westendorp RGJ. (2000) C-reactive protein is a strong but non-specific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol 20: 1047-1051.
80. Zaremba J, Losy J. The levels of TNF-alpha in cerebrospinal fluid and serum do not correlate with the counts of the white blood cells in acute phase of ischaemic stroke. Folia Morphol (Warsz) 2001; 60: 91-97 (Pubitemid 32509970)
81. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE. Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol 2004; 137: 117-122 (Pubitemid 38869785)
82. Vila N, Filella X, Deulofeu R, Ascaso C, Abellana R, Chamorro A. Cytokine-induced inflammation and long-term stroke functional outcome. J Neurol Sci 1999; 162: 185-188 (Pubitemid 29125251)
83. Emsley HC, Smith CJ, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003; 139: 93-101.
84. Chuaqui R, Tapia J. Histologic assessment of the age of recent brain infarcts in man. J Neuropathol Exp Neurol 1993; 52: 481-489 (Pubitemid 23269196)
85. Mena H, Cadavid D, Rushing E. Human cerebral infarct: a proposed histopathologic classification based on 137 cases. Acta Neuropathol (Berl).